Moderator
Vicky Goh, London/United Kingdom
Registration fees
To register please enter ESR Connect.
ESR members EUR 99
Non-members EUR 149
Registration fees do not include VAT. VAT will be added during the registration process and will be calculated based on your country or disclosure of the VAT number of your company.
Registration fees include on-demand access until February 3, 2022.
(If you need to renew or apply for the ESR membership for 2021, please click here)
CME accreditation
ONLY for Live Streaming
An application for this online event has been made to the European Accreditation Council for Continuing Medical Education (EACCME) for CME accreditation. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.eu.
The maximum number of CME credits designated for this event is announced on the event website as soon as the application process has been finalised.
CME credits are only available when participating in the actual live streaming and after completion of an online evaluation form. No CME credits are availalbe when watching on demand.
Asklepios Course
ONCOLOGIC IMAGING ONLINE | November 3, 2021
Course information
This course is aimed at senior residents and recently board-certified radiologists, interested in oncologic imaging. This course will cover essentials for practice in terms of diagnostic criteria and staging and pearls and pitfalls of imaging of a variety of neoplasms. This course will also introduce recently proposed risk-stratification systems and highlight the application of the latest imaging techniques in oncologic imaging. Internationally renowned European experts will ensure a high-quality teaching programme combining lectures and interactive cases.
Learning objectives
Following this course, participants will be able to:
- Describe current imaging protocols and practice for the diagnosis and assessment of some of the most frequent/important cancers
- Explain the necessity of staging for appropriate therapy planning and correct estimation of prognosis
- Apply the latest risk stratification algorithms for improving prediction of clinically significant cancer
- Consider the evolving role and potential of different imaging modalities in the multidisciplinary management of some of the most frequent/important cancers
Programme Online
Wednesday, November 3, 2021
| 10:00-10:30 | Brain tumours: Essentials for practice M. Smits, Rotterdam/NL |
| 10:30-11:00 | Head and neck cancer: What the clinicians want to know M. Becker, Geneva/CH |
| 11:00-11:30 | Lung cancer screening: Pearls and pitfalls H.-U. Kauczor, Heidelberg/DE |
| 11:30-11:40 | Q&A |
| 11:40-12:25 | Break |
| 12:25-12:55 | Imaging uterine tumours: Pearls and pitfalls R. Forstner, Salzburg/AT |
| 12:55-13:25 | O-RADS MRI: How to apply this? A. Rockall, London/UK |
| 13:25-13:55 | Imaging nodes in cancer: Introducing node-RADS F. Elsholtz, Berlin/DE |
| 13:55-14:05 | Q&A |
| 14:05-14:50 | Break |
| 14:50-15:20 | Renal lesions: Benign or malignant? D. Prezzi, London/UK |
| 15:20-15:50 | Prostate cancer: An update on PSMA imaging G. Cook, London/UK |
| 15:50-16:20 | Whole body MRI for oncologic imaging V. Goh, London/UK |
| 16:20-16:30 | Q&A |